22 European institutions join forces in MICROB-PREDICT to improve the prevention and treatment of chronic liver disease (cirrhosis). We aim to identify microbiome-based biomarkers and mechanisms that predict in advance when the body can no longer compensate for the dysfunctional…
A-TANGO strives to increase the survival rate with G-TAK – a novel combinatorial therapy, and to decrease the burden on the national healthcare systems, which is caused by a large percentage of patients who never recover fully and require long-term care.
Liver diseases pose a significant global health challenge, with conditions like liver fibrosis often remaining undetected until they reach advanced stages, leading to severe consequences such as cirrhosis and liver cancer. In response to this pressing issue, the LIVERSCREEN project aims to…
DECISION strives to better understand the pathophysiology of decompensated cirrhosis leading to acute-on-chronic liver failure (ACLF) at the systems level by taking advantage of already existing large and clinically well-characterized patient cohorts. The ultimate goal is to significantly reduce mortality…
The EASL Nurses & AHPs Task Force is delighted to announce this call. We are looking for the next “Rising Star” in our community of liver nurses and Allied Health Professionals (AHPs). Click to see a non-exhaustive list of professions that can…
The EASL Congress 2023 is around the corner, and we are looking for our next awardees to celebrate.
The EASL Congress has been gathering experts from around the world to beat liver disease, since 1966. It has since become the place to be, to learn, share and interact with the global liver community. We aim to bring together…